GV 2017 GP, L.L.C.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$39.11M

Insider Activity of GV 2017 GP, L.L.C.

The largest sale of all time was on 2022-11-04 and amounted to 194332 shares of Verve Therapeutics, Inc. for $6.05M.

Biography of GV 2017 GP, L.L.C.

No biography is available at this moment.

2022-11-04SaleAlphabet Inc.
GOOG
director
97,166
0.0003%
$31.14$3.03M+25.61%
2022-11-04SaleVerve Therapeutics, Inc.
VERV
director
194,332
1.0902%
$31.14$6.05M-43.27%
2022-11-03SaleAlphabet Inc.
GOOG
director
99,137
0.0003%
$32.79$3.25M+30.37%
2022-11-03SaleAlphabet Inc.
GOOG
director
71,847
0.0002%
$32.65$2.35M+30.37%
2022-11-03SaleVerve Therapeutics, Inc.
VERV
director
99,137
0.567%
$32.79$3.25M-44.93%
2022-11-03SaleVerve Therapeutics, Inc.
VERV
director
71,847
0.4091%
$32.65$2.35M-44.93%
2022-11-02SaleAlphabet Inc.
GOOG
director
48,373
0.0002%
$35.79$1.73M+24.71%
2022-11-02SaleAlphabet Inc.
GOOG
director
28,652
<0.0001%
$35.94$1.03M+24.71%
2022-11-02SaleVerve Therapeutics, Inc.
VERV
director
48,373
0.2822%
$35.79$1.73M-48.38%
2022-11-02SaleVerve Therapeutics, Inc.
VERV
director
38,001
0.2209%
$35.66$1.35M-48.38%
2022-11-01SaleAlphabet Inc.
GOOG
director
63,926
0.0002%
$36.79$2.35M+19.67%
2022-11-01SaleVerve Therapeutics, Inc.
VERV
director
63,926
0.3638%
$36.79$2.35M-50.88%
2022-10-31SaleAlphabet Inc.
GOOG
director
107,305
0.0003%
$38.64$4.15M+14.34%
2022-10-31SaleVerve Therapeutics, Inc.
VERV
director
107,305
0.6199%
$38.64$4.15M-52.36%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.